BOCCANEGRA, BRIGIDA
 Distribuzione geografica
Continente #
NA - Nord America 271
EU - Europa 109
AS - Asia 30
SA - Sud America 1
Totale 411
Nazione #
US - Stati Uniti d'America 269
IT - Italia 70
SE - Svezia 19
SG - Singapore 12
CN - Cina 10
GB - Regno Unito 8
CZ - Repubblica Ceca 6
VN - Vietnam 4
BE - Belgio 2
CA - Canada 2
FI - Finlandia 2
IN - India 2
BR - Brasile 1
HK - Hong Kong 1
JP - Giappone 1
NL - Olanda 1
NO - Norvegia 1
Totale 411
Città #
Chandler 44
Fairfield 29
Nyköping 19
Ashburn 16
Milan 16
Seattle 15
Woodbridge 15
Cambridge 13
Houston 13
New York 12
Bari 9
Singapore 9
Wilmington 8
Brno 6
Des Moines 6
Lawrence 6
Taranto 6
Ann Arbor 5
Inglewood 5
Dong Ket 4
Modugno 4
Albairate 3
Princeton 3
Roxbury 3
Adelfia 2
Barletta 2
Brescia 2
Brussels 2
Gioia Del Colle 2
Helsinki 2
London 2
Nanjing 2
Naples 2
Nulvi 2
San Diego 2
Santa Clara 2
St Helens 2
Toronto 2
Trieste 2
Amsterdam 1
Beijing 1
Brooklyn 1
Clifton 1
Hong Kong 1
Jiangmen 1
Jiaxing 1
Kagoya 1
Kilburn 1
Los Angeles 1
Messina 1
Mumbai 1
Padova 1
Primavera do Leste 1
Pune 1
Tromsø 1
Valenzano 1
Wuxi 1
Totale 317
Nome #
Dasatinib/HP-β-CD inclusion complex based aqueous formulation as a promising tool for the treatment of paediatric neuromuscular disorders 130
Safety issues and harmful pharmacological interactions of nutritional supplements in Duchenne muscular dystrophy: considerations for Standard of Care and emerging virus outbreaks 65
Ergogenic effect of bcaas and l-alanine supplementation: Proof-of-concept study in a murine model of physiological exercise 59
BCAAs and Di-Alanine supplementation in the prevention of skeletal muscle atrophy: preclinical evaluation in a murine model of hind limb unloading 38
β‐Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation 37
Circadian Genes as Exploratory Biomarkers in DMD: Results From Both the mdx Mouse Model and Patients 28
Blockers of Skeletal Muscle Nav1.4 Channels: From Therapy of Myotonic Syndrome to Molecular Determinants of Pharmacological Action and Back. 16
Branched-Chain Amino Acids and Di-Alanine Supplementation in Aged Mice: A Translational Study on Sarcopenia 15
Growth hormone secretagogues modulate inflammation and fibrosis in mdx mouse model of Duchenne muscular dystrophy 13
LKB1 signaling is altered in skeletal muscle of a Duchenne muscular dystrophy mouse model 13
Preclinical Ultrasonography in Rodent Models of Neuromuscular Disorders: The State of the Art for Diagnostic and Therapeutic Applications 13
Ion channels as biomarkers of altered myogenesis in myofiber precursors of Duchenne muscular dystrophy 6
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 3
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence 3
Preclinical study of the antimyotonic efficacy of safinamide in the myotonic mouse model 2
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 2
Totale 443
Categoria #
all - tutte 3.437
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.437


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202025 0 0 0 0 5 2 2 7 4 3 0 2
2020/202161 2 2 0 19 3 0 0 4 12 7 6 6
2021/202252 4 0 2 0 0 2 8 0 5 7 11 13
2022/2023116 9 16 7 10 8 10 7 11 17 1 11 9
2023/2024101 2 16 7 10 6 17 1 4 7 15 6 10
2024/202543 11 0 12 12 8 0 0 0 0 0 0 0
Totale 443